1015-P: Effects of the Oral, Small Molecule GLP-1R Agonist TTP273 on Patients With Stage 2 Hypertension: Results From a Post Hoc Analysis of the Phase 2 Logra Study
Diabetes - United States
doi 10.2337/db19-1015-p
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
American Diabetes Association